News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Prollenium Medical Technologies Announces Partnership Agreement with Ajanta Pharma to Market Revanesse(R) in India


9/17/2007 2:42:22 PM

RICHMOND HILL, ON, Sept. 17 /CNW/ - Ajanta Pharma has entered into an in-licensing agreement with Prollenium Medical Technologies of Canada and will have exclusive marketing rights for Prollenium's highly successful dermal filler 'Revanesse(R)' in India.

Read at Canada NewsWire


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES